UroGen Pharma Ltd. (URGN)
11.35
0.34 (3.09%)
At close: Jan 30, 2025, 3:59 PM
11.35
0.00%
After-hours Jan 30, 2025, 04:00 PM EST
Cashflow (Annual)
Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 |
| Net Income | -102.24M | -109.78M | -110.82M | -128.48M | -105.15M | -75.66M | -20.00M | -1.94M | -12.69M | -4.48M | -3.31M |
| Depreciation & Amortization | 1.71M | 1.82M | 1.77M | 2.04M | 1.32M | 417.00K | 207.00K | 213.00K | 113.00K | 30.00K | 18.00K |
| Stock-Based Compensation | 9.34M | 10.58M | 23.11M | 28.02M | 29.97M | 30.64M | 6.30M | 1.97M | 449.00K | 293.00K | 541.00K |
| Other Working Capital | 3.27M | -5.24M | -7.57M | 3.89M | 1.39M | -650.00K | 1.35M | 917.00K | -546.00K | -162.00K | 13.00K |
| Other Non-Cash Items | 11.48M | 16.13M | -1.18M | -1.54M | -910.00K | 100.00K | 165.00K | 2.74M | 4.10M | 198.00K | 177.00K |
| Deferred Income Tax | n/a | n/a | 15.32M | 439.00K | -572.00K | n/a | n/a | n/a | 240.00K | n/a | n/a |
| Change in Working Capital | 3.34M | -6.31M | -13.11M | -6.37M | 4.32M | 7.16M | 3.76M | 1.21M | 609.00K | -162.00K | 13.00K |
| Operating Cash Flow | -76.38M | -87.56M | -84.89M | -105.89M | -71.02M | -37.33M | -9.57M | 4.19M | -7.17M | -4.12M | -2.56M |
| Capital Expenditures | -194.00K | -254.00K | -752.00K | -1.22M | -325.00K | -560.00K | -271.00K | -695.00K | -301.00K | -24.00K | -57.00K |
| Acquisitions | n/a | -1.31M | -4.82M | -94.45M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Purchase of Investments | -49.83M | -63.01M | -51.90M | -29.69M | -197.69M | -54.00K | -36.00M | -24.00K | n/a | n/a | n/a |
| Sales Maturities Of Investments | 49.07M | 64.32M | 56.72M | 124.14M | 52.59M | 35.90M | n/a | n/a | n/a | n/a | n/a |
| Other Investing Acitivies | n/a | 1.31M | 4.82M | 94.45M | -172.00K | -54.00K | -105.00K | -98.00K | n/a | 23.00K | -32.00K |
| Investing Cash Flow | -953.00K | 1.06M | 4.07M | 93.24M | -145.59M | 35.29M | -36.38M | -793.00K | -301.00K | -1K | -89.00K |
| Debt Repayment | n/a | 95.78M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 647.00K | n/a |
| Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Financial Acitivies | 49.57M | 1.35M | 72.32M | 674.00K | 3.59M | 2.19M | 744.00K | -9.00K | 21.58M | 4.30M | 3.47M |
| Financial Cash Flow | 116.93M | 97.13M | 72.32M | 16.53M | 165.25M | 66.42M | 61.59M | -9.00K | 21.58M | 4.95M | 3.47M |
| Net Cash Flow | 39.60M | 10.63M | -8.50M | 3.88M | -51.36M | 64.37M | 15.64M | 3.39M | 14.11M | 833.00K | 822.00K |
| Free Cash Flow | -76.57M | -87.81M | -85.64M | -107.10M | -71.34M | -37.89M | -9.84M | 3.49M | -7.48M | -4.14M | -2.61M |